Telomeres,Telomerase,CellularAging,andImmortality

Telomeres, which define the ends of chromosomes, consist of short, tandemly repeated DNA sequences loosely conserved in eukaryotes. Telomerase is a ribonucleoprotein complex ( we only show a few of the components in this illustration) which in vitro recognizes a single-stranded G-rich telomere primer and adds multiple telomeric repeats to its 3-prime end by using an RNA template. Telomerase may also have a role in de novo formation of telomeres. Telomerase has been identified in many cultured cell lines and actively dividing cell types. The active reverse transcriptase component has been identified in teh TERT protein. The presence of this factor determines the availability of the telomerase function. The TERT protein has a high turnover rate and its expression is regulated by factors that promote growth (c-MYC, v-k-ras, Bcl-2 and E6) and inhibiting factors (RB and p53) that promote cell death or that block cell division. It appears that the regulation of active telomerase has many levels and can be inhibited by TEP1 not releasing TERT or by TRF1 which binds the end repeats and prevents access to the chromosome ends. Additional modulation is due to phosphorlyation by PKC and AKT or dephophorylation by PP2A. Wilke et al found that a case of human alpha-thalassemia was caused by a truncation of chromosome 16 that had been healed by the addition of telomeric repeats (TTAGGG)n. Human telomeres consist of many kilobases of (TTAGGG)n together with various associated proteins. Small amounts of these terminal sequences are lost from the tips of the chromosomes during each S phase because of incomplete DNA replication, but de novo addition of TTAGGG repeats by the enzyme telomerase compensates for this loss. Many human cells progressively lose terminal bases with each cell division, a loss that correlates with the apparent absence of telomerase in these cells. There has been considerable interest in the possible relationship between human telomeres and cellular senescence and immortalization. This interest includes the question of a role in the malignant process and the question of the use of telomerase inhibitors as anti-tumor drugs.

Contributor: Kosi Gramatikoff, PhD

REFERENCES: Chai W, Ford LP, Lenertz L, Wright WE, Shay JW. Human Ku70/80 associates physically with telomerase through interaction with hTERT. J Biol Chem. 2002 Dec 6;277(49):47242-7. Chang S, DePinho RA. Telomerase extracurricular activities. Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12520-2. No abstract available. Dahse R, Fiedler W, Ernst G. Telomeres and telomerase: biological and clinical importance. Clin Chem. 1997 May;43(5):708-14. Review. Fossel, M. Telomerase and the aging cell: implications for human health. J.A.M.A. 279: 1732-1735, 1998. Haendeler J, Hoffmann J, Rahman S, Zeiher AM, Dimmeler S. Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation. FEBS Lett. 2003 Feb 11;536(1-3):180-6. Hess JL, Highsmith WE Jr. Telomerase detection in body fluids. Clin Chem. 2002 Jan;48(1):18-24. Review. Kipling, D. Telomerase: immortality enzyme or oncogene? Nature Genet. 9: 104-106, 1995. Lenk U, Yu H, Walter J, Gelman MS, Hartmann E, Kopito RR, Sommer T. A role for mammalian Ubc6 homologues in ER-associated protein degradation. J Cell Sci. 2002 Jul 15;115(Pt 14):3007-14. Liu JP. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J. 1999 Dec;13(15):2091-104. Review. Okabe J, Eguchi A, Masago A, Hayakawa T, Nakanishi M. TRF1 is a critical trans-acting factor required for de novo telomere formation in human cells. Hum Mol Genet. 2000 Nov 1;9(18):2639-50. Saldanha SN, Andrews LG, Tollefsbol TO. Assessment of telomere length and factors that contribute to its stability. Eur J Biochem. 2003 Feb;270(3):389-403. Review. Shay, J. W.; Zou, Y.; Hiyama, E.; Wright, W. E. Telomerase and cancer. Hum. Molec. Genet. 10: 677-685, 2001. Stewart SA, Hahn WC, OConnor BF, Banner EN, Lundberg AS, Modha P, Mizuno H, Brooks MW, Fleming M, Zimonjic DB, Popescu NC, Weinberg RA. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12606-11. Wang, J.; Hannon, G. J.; Beach, D. H. Risky immortalization by telomerase. (Letter) Nature 405: 755-756, 2000. Wilke et. Al. Nature 1990 Aug. 30; 346 (6287); 868-71 Wu, K.-J.; Grandori, C.; Amacker, M.; Simon-Vermot, N.; Polack, A.; Lingner, J.; Dalla-Favera, R. Direct activation of TERT transcription by c-MYC. Nature Genet. 21: 220-224, 1999.